Page 96 - 《中国药房》2023年1期
P. 96

基于 AHP-TOPSIS 法的阿托西班临床合理用药评价标准的建立

          与应用
                     Δ


                                               1, 2
                                                         1, 2
                                                                  1, 2 #
                                      1, 2
                            2, 3
          殷锦锦    1, 2* ,杜培丽 ,谭湘萍 ,梅峥嵘 ,施胜英 ,刘少志 (1.广州医科大学附属第三医院药学部,广州
          510150;2. 广东省产科重大疾病重点实验室,广州 510150;3. 广州医科大学附属第三医院产科,广州
          510150)
          中图分类号  R984      文献标志码  A      文章编号  1001-0408(2023)01-0086-05
          DOI  10.6039/j.issn.1001-0408.2023.01.17


          摘   要  目的  建立阿托西班的临床合理用药评价标准,为临床合理使用阿托西班提供参考。方法  以醋酸阿托西班注射液说明
          书、相关指南为依据,由合理用药评价小组制定合理用药评价标准,包括5个一级指标、8个二级指标。采用层次分析(AHP)法计
          算二级指标的权重系数,利用逼近理想值排序(TOPSIS)法对广州医科大学附属第三医院(以下简称“本院”)190例妊娠期妇女使
          用醋酸阿托西班注射液的情况进行回顾性评价,根据相对接近度将评价结果分为用药合理、用药基本合理、用药不合理3个层次。
          结果  190例妊娠期妇女中,49例(25.8%)为阿托西班用药合理,39例(20.5%)为用药基本合理,102例(53.7%)为用药不合理;AHP-
          TOPSIS法所得评价结果与临床实际情况相符。用药不合理的主要问题为超适应证用药、用法用量不合理、超疗程用药及未进行
          适宜的经济性考量。结论  通过AHP-TOPSIS法建立了阿托西班临床应用的合理性评价标准,该法所得评价结果可量化、科学可
          信。该药在本院的不合理使用现象较为普遍,临床应用时应加强管理。
          关键词  阿托西班;合理用药;评价标准;层次分析法;逼近理想值排序法

          Establishment  and  application  of  evaluation  criteria  for  clinical  rational  drug  use  of  atosiban  based  on
          AHP-TOPSIS method
                                                1, 2
                               2, 3
                   1, 2
                                                                                                1, 2
                                                                                  1, 2
          YIN Jinjin ,DU Peili ,TAN Xiangping ,MEI Zhengrong ,SHI Shengying ,LIU Shaozhi (1.  Dept.  of
                                                                 1, 2
          Pharmacy,  the  Third  Affiliated  Hospital  of  Guangzhou  Medical  University,  Guangzhou  510150,  China;
          2.  Guangdong  Provincial  Key  Laboratory  of  Obstetrics  Major  Diseases,  Guangzhou  510150,  China;3.  Dept.  of
          Obstetrics, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China)
          ABSTRACT    OBJECTIVE To establish evaluation criteria for rational drug use of atosiban in clinic, and to provide reference for
          rational  drug  use  of  atosiban  in  clinic.  METHODS  Based  on  the  drug  instructions  of  atosiban  acetate  injection  and  related
          guidelines,  the  experts  of  the  Evaluation  Group  of  Rational  Drug  Use  formulated  the  evaluation  criteria  of  rational  drug  use,
          including  5  primary  indexes  and  8  secondary  indexes.  The  weight  coefficients  of  secondary  indexes  were  calculated  by  analytic
          hierarchy  process (AHP),  and  the  use  of  atosiban  acetate  injection  in  190  pregnant  women  from  the  Third Affiliated  Hospital  of
          Guangzhou  Medical  University (referred  to  as “our  hospital”)  was  evaluated  retrospectively  by  technique  for  order  preference  by
          similarity  to  an  ideal  solution (TOPSIS).  The  evaluation  results  were  divided  into  three  levels  including  reasonable,  basic
          reasonable  and  unreasonable  application  based  on  the  relative  approach  degree.  RESULTS  Among  190  pregnant  women,  49
         (25.8%)  were  treated  with  atosiban  reasonably,  39 (20.5%)  were  treated  with  atosiban  basic  reasonably,  and  102 (53.7%)  were
          treated with atosiban unreasonably. The evaluation results obtained by AHP-TOPSIS method were consistent with the actual situation
          in  clinic.  The  main  problems  of  the  unreasonably  use  were  super  indications,  unreasonable  usage  and  dosage,  over  the  course  of
          treatment  and  the  lack  of  proper  economic  consideration.  CONCLUSIONS  The  rationality  evaluation  criteria  of  atosiban’s  clinical
          application  are  established  by AHP-TOPSIS  method;  the  evaluation  results  obtained  by  this  method  are  quantifiable,  scientific  and
                                                              reliable.  The  unreasonable  use  of  atosiban  is  common  in  our
              Δ 基金项目 广东省医学科学技术研究基金项目(No.A2020161,
          No.B2018191);广东省医院药学研究基金项目(No.2016MZ05);广州          hospital,  and  the  management  should  be  strengthened  in
          市科技计划项目(No.202201020390)                            clinical application.
             *第一作者 主管药师,硕士。研究方向:医院药学。电话:020-                  KEYWORDS    atosiban;  rational  drug  use;  evaluation  criteria;
          81292708。E-mail:yinjinjinsunny@163.com
              # 通信作者 主管药师,硕士。研究方向:医院药学。电话:020-                analytic  hierarchy  process;  technique  for  order  preference  by
          81298393。E-mail:shaozhiliu@126.com                  similarity to an ideal solution


          · 86 ·    China Pharmacy  2023 Vol. 34  No. 1                                中国药房  2023年第34卷第1期
   91   92   93   94   95   96   97   98   99   100   101